Heidelberg, Germany, Gembloux, Belgium, and Shanghai, China — September 3, 2024 — Full-Life Technologies, a fully integrated global radiotherapeutics company, today announced attendance of the Morgan Stanley 22nd Annual Global Healthcare Conference in New York. Lanny Sun, Co-founder, Chairman & Chief Executive Officer, will be presenting on September 6, 2024, 1:50 to 2:25 p.m. ET.

About Full-Life Technologies

Full-Life Technologies ("Full-Life") is a fully integrated global radiotherapeutics company with operations in Belgium, Germany, and China. We aim to own the entire value chain for radiopharmaceutical research & development, production & commercialization to deliver clinical impact for patients. The Company endeavors to tackle fundamental challenges affecting radiopharmaceuticals today by pioneering innovative research that will shape the treatments of tomorrow. We are comprised of a team of fast-moving entrepreneurs and seasoned scientists with a proven history of success in the life sciences, alongside radioisotope research and clinical development.